When a drug is used more widely, harms can become more visible at a population level, which may influence how experts assess harms to others. Next week: methamphetamine and crime. Receipts: doi.org/10.1177/0269... doi.org/10.1177/0269... doi.org/10…
Next time we will look more closely at how these studies define and measure harm, and why this matters. Receipts: journals.sagepub.com/doi/10.1177/... journals.sagepub.com/doi/10.1177/... www.thelancet.com/journals/lan... journals.sagepub.com/doi/10…
RP @publicaddress.bsky.social: Anyway, here's the 2023 Otago study. It will be interesting to compare with the Massey work as more data emerges. And we can only hope that one day, the day we regulate drugs will reflect the actual evidence. pmc.ncbi.nlm.…
Anyway, here's the 2023 Otago study. It will be interesting to compare with the Massey work as more data emerges. And we can only hope that one day, the day we regulate drugs will reflect the actual evidence. pmc.ncbi.nlm.nih.gov/articles/PMC...